The efficacy of atherectomy combined with percutaneous transluminal angioplasty (PTA)/drug-coated balloon (DCB) compared with PTA/DCB for infrapopliteal arterial diseases: A systematic review and meta-analysis

Abstract

Objectives

With the development of endovascular therapies, some studies have indicated a therapeutic potential for infrapopliteal arterial revascularization with atherectomy (AT). This study was designed to perform a meta-analysis to investigate the efficacy of AT combined with percutaneous transluminal angioplasty (PTA) or drug-coated balloon (DCB) compared with PTA or DCB for infrapopliteal arterial diseases.

Methods

This is a systematic review and meta-analysis. The Pubmed, Web of Science, and Cochrane Library were systematically searched for articles published up to November 2022, reporting using atherectomy devices for infrapopliteal arterial patients. Randomized controlled trials and retrospective studies were included, and clinical characteristic outcomes were extracted and pooled. Then, we analyzed the efficacies of the AT (AT + PTA or DCB) group and the non-AT (DCB or PTA) group for infrapopliteal arterial patients.

Results

We identified 6 studies with 1269 patients included in this meta-analysis. The risk ratios (RRs) of primary patency for patients treated with atherectomy group compared to non-atherectomy group at 6 months was 1.03 (95% confidence intervals (CIs) 0.86–1.23, p = .74), at 12 months was 1.05 (95% CIs 0.84–1.30, p = .66), in the subgroup analysis between AT combined with DCB and DCB alone, the RRs of primary patency was 1.56 (95% CIs 1.02–2.39, p = .04). The RRs of freedom from target lesion revascularization (TLR) at 6 months was 1.04 (95% CIs 0.93–1.17, p = .45), at 12 months was 1.20 (95% CIs 0.83–1.75, p = .33). The RRs of mortality at 6 months was 0.57 (95% CIs 0.29–1.11, p = .10), and at 12 months was 0.79 (95% CI 0.50–1.25, p = .31). The RRs of limb salvage at 12 months was 0.99 (95% CIs 0.92–1.07, p = .87). The standardized mean difference (SMD) of (Ankle-brachial index) ABI at 12 months was 0.16 (95% CIs 0.06–0.26, p = .001).

Conclusions

According to this systematic review and meta-analysis, no significant advantages were found with the addition of atherectomy to balloon angioplasty in the below-the-knee segment. Only in the analysis of a small subgroup of atherectomy + DCB versus DCB alone was the primary patency rate at six months significantly higher when adding atherectomy. No further significant differences were found related to 12 months of primary patency, TLR, limb salvage, and mortality among groups.

Keywords

Debulking devices atherectomy drug-coated balloon percutaneous transluminal angioplasty infrapopliteal arterial diseases

Get full access to this article

View all access options for this article.

References

Tummala

Amin

Mehta

. Infrapopliteal artery occlusive disease: an overview of vessel preparation and treatment options. J Clin Med 2020; 9(10): 3321.

Hirsch

Haskal

Hertzer

, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) endorsed by the American association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; TransAtlantic inter-society consensus; and vascular disease foundation. J Am Coll Cardiol 2006; 47(6): 1239–1312.

Norgren

Hiatt

Dormandy

, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45(Suppl S): S5–67.

Committee

Jaff

White

, et al. An update on methods for revascularization and expansion of the tasc lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). J Endovasc Ther 2015; 22(5): 663–677.

Gargiulo

3rd O’Connor

. Proportion of patients with critical limb ischemia who require an open surgical procedure in a center favoring endovascular treatment. Am Surg 2011; 77(3): 315–321.

Mustapha

Finton

Diaz-Sandoval

, et al. Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis. Circ Cardiovasc Interv 2016; 9(5): e003468.

Katsanos

Spiliopoulos

Reppas

, et al.

Debulking atherectomy in the peripheral arteries: is there a role and what is the evidence?

Cardiovasc Intervent Radiol 2017; 40(7): 964–977.

Diamantopoulos

Katsanos

. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Surg 2014; 55(5): 655–665.

Moher

Liberati

Tetzlaff

, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.

10.

Higgins

Green

. Cochrane handbook for systematic reviews of interventions version 5.0.2. London: The Cochrane Collaboration, 2009.

11.

Wells

Shea

O’Connell

, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON: Ottawa: Hospital Research Institute, 2000.

12.

Borenstein

Hedges

Higgins

, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010; 1(2): 97–111.

13.

Nikolakopoulou

Mavridis

Salanti

. Demystifying fixed and random effects meta-analysis. Evid Base Ment Health 2014; 17(2): 53–57.

14.

Kokkinidis

Giannopoulos

Jawaid

, et al. Laser atherectomy for infrapopliteal lesions in patients with critical limb ischemia. Cardiovasc Revascularization Med 2021; 23: 79–83.

15.

Rastan

Brodmann

Bohme

, et al. Atherectomy and drug-coated balloon angioplasty for the treatment of long infrapopliteal lesions: a randomized controlled trial. Circ Cardiovasc Interv 2021; 14(6): e010280.

16.

Shammas

Lam

Mustapha

, et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther 2012; 19(4): 480–488.

17.

Zia

Juneja

Shams

, et al. Contemporary outcomes of infrapopliteal atherectomy with angioplasty versus balloon angioplasty alone for critical limb ischemia. J Vasc Surg 2020; 71(6): 2056–2064.

18.

Todd

Jr. Ahanchi

Maurer

, et al. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg 2013; 58(4): 941–948.

19.

Zeller

Giannopoulos

Brodmann

, et al. Orbital atherectomy prior to drug-coated balloon angioplasty in calcified infrapopliteal lesions: a randomized, multicenter pilot study. J Endovasc Ther 2022; 29: 15266028211070968.

20.

Mohler

3rd Giri

. Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines. Curr Med Res Opin 2008; 24(9): 2509–2522.

21.

Giannopoulos

Varcoe

Lichtenberg

, et al. Balloon angioplasty of infrapopliteal arteries: a systematic review and proposed algorithm for optimal endovascular therapy. J Endovasc Ther 2020; 27(4): 547–564.

22.

Giordano

Peruzzi

Frati

, et al. Commentary: identifying the best device for infrapopliteal revascularization through quantitative evidence synthesis. J Endovasc Ther 2016; 23(6): 864–866.

23.

Bosiers

Hart

Deloose

, et al. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 2006; 14(2): 63–69.

24.

Schillinger

Exner

Mlekusch

, et al. Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology 2003; 227(2): 419–425.

25.

Yongquan

Lianrui

Lixing

, et al. Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter. Int Angiol 2013; 32(4): 362–367.

26.

Safian

Niazi

Runyon

, et al. Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the OASIS trial. Cathet Cardiovasc Interv 2009; 73(3): 406–412.

27.

Akkus

Abdulbaki

Jimenez

, et al. Atherectomy devices: technology update. Med Devices (Auckl) 2015; 8: 1–10.

28.

Bosiers

Peeters

Elst

, et al. Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study. Eur J Vasc Endovasc Surg 2005; 29(6): 613–619.

29.

Stanek

. Laser angioplasty of peripheral arteries: basic principles, current clinical studies, and future directions. Diagn Interv Radiol 2019; 25(5): 392–397.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.28 MB